Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Chickenpox - Evidence
References

All references with links to [Free Full-text] are freely available online to users in the UK. Links to PubMed abstracts are also provided where available. CKS is not responsible for the content of external sites.

Free Full-text links are to dynamic documents that may have been updated since they were originally cited in the CKS topic. All links are checked regularly by CKS Information Specialists and updated to the latest version. Changes in the content of updated documents will not be reflected in the CKS topic text until the next revision.

The following references were cited in January 2008. References dated after this reflect new evidence incorporated since original publication of this topic.

  1. ABPI Medicines Compendium (2002) Summary of product characteristics for Calamine Lotion BP. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
  2. ABPI Medicines Compendium (2005a) Summary of product characteristics for Piriton syrup. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
  3. ABPI Medicines Compendium (2005b) Summary of product characteristics for Piriton tablets. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
  4. ABPI Medicines Compendium (2007) Summary of product characteristics for Zovirax 800mg tablets. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
  5. Allen, S. (2006) Chickenpox and shingles infection. Pharmaceutical Journal 277(7422), 453-456. [Free Full-text]
  6. Bernhardt, D.T. (1991) Topical diphenhydramine toxicity. Wisconsin Medical Journal 90(8), 469-471. [Abstract]
  7. BNF 54 (2007) British National Formulary. 54th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
  8. Bovill, B. and Bannister, B. (1998) Review of 26 years' hospital admissions for chickenpox in North London. Journal of Infection 36(Suppl 1), 17-23. [Abstract]
  9. Chan, C.Y. and Wallander, K.A. (1991) Diphenhydramine toxicity in three children with varicella-zoster infection. Annals of Pharmacotherapy 25(2), 130-132. [Abstract]
  10. DH (2006) Immunisation against infectious disease - "The Green Book". Chapter 34 - varicella. Department of Health. www.dh.gov.uk [Free Full-text]
  11. DTB (2005a) Chickenpox, pregnancy and the newborn. Drug & Therapeutics Bulletin 43(9), 69-72. [Abstract]
  12. DTB (2005b) Chickenpox, pregnancy and the newborn: a follow-up. Drug & Therapeutics Bulletin 43(12), 94-95. [Abstract]
  13. Englisch, W. and Bauer, C.P. (1997) Dimethindene maleate in the treatment of pruritus caused by varizella zoster virus infection in children. Arzneimittelforschung 47(11), 1233-1235. [Abstract]
  14. Guess, H.A., Broughton, D.D., Melton, L.J. and Kurland, L.T. (1986) Population-based studies of varicella complications. Pediatrics 78(4 Pt 2), 723-727. [Abstract]
  15. Heininger, U. and Seward, J.F. (2006) Varicella. Lancet 368(9544), 1365-1376. [Abstract]
  16. HPA (2006) General information: chickenpox (Varicella). Health Protection Agency. www.hpa.org.uk [Free Full-text]
  17. HPA (2007a) Guidance on the management of rash illness and the exposure to rash illness in pregnancy. Health Protection Agency. www.hpa.org.uk [Free Full-text]
  18. HPA (2007b) Management of vesicular rash (varicella/herpes zoster) in pregnancy. Guidance on the management of rash illness and exposure to rash illness in pregnancy. Health Protection Agency. www.hpa.org.uk [Free Full-text]
  19. HPA and Association of Medical Microbiologists (2010) Management of infection guidance for primary care for consultation and local adaptation. Health Protection Agency. www.hpa.org.uk [Free Full-text]
  20. Huston, R.L., Cypcar, D., Cheng, G.S. and Foulds, D.M. (1990) Toxicity from topical administration of diphenhydramine in children. Clinical Pediatrics 29(9), 542-545.
  21. Isaacs, D. (2000) Neonatal chickenpox. Journal of Paediatrics and Child Health 36(1), 76-7.
  22. Klassen, T.P., Hartling, L., Wiebe, N. and Belseck, E.M. (2005) Acyclovir for treating varicella in otherwise healthy children and adolescents (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
  23. Kubeyinje, E.P. (1995) Varicella infection in Saudi children with atopic eczema. Medical Science Research 23(9), 591-592.
  24. Lawrence, R.A. and Lawrence, R.M. (1999) Breastfeeding: a guide for the medical professional. St Louis: Mosby.
  25. Lesko, S.M. and Mitchell, A.A. (1995) An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. Journal of the American Medical Association 273(12), 929-933. [Abstract]
  26. Lichenstein, R. (2006) Pediatrics, chicken pox or varicella. emedicine. WebMD. www.emedicine.com
  27. McGann, K.P., Pribanich, S., Graham, J.A. and Browning, D.G. (1992) Diphenhydramine toxicity in a child with varicella A case report. Journal of Family Practice 35(2), 213-214. [Abstract]
  28. Morgan-Capner, P., Crowcroft, N.S. and PHLS Joint Working Party of the Advisory Committee of Virology and Vaccines and Immunisation (2002) Guidelines on the management of, and exposure to rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). Communicable Disease and Public Health 5(1), 59-71. [Abstract] [Free Full-text]
  29. Nathwani, D., Maclean, A., Conway, S. and Carrington, D. (1998) Varicella infections in pregnancy and the newborn: a review prepared for the UK Advisory Group on chickenpox on behalf of the British Society for the Study of Infection. Journal of Infection 36(Suppl 1), 59-71.
  30. NICE (2007a) Feverish illness in children. Assessment and the initial management in children younger than 5 years: quick reference guide. National Institute for Health and Clinical Excellence. www.nice.org.uk [Free Full-text]
  31. NICE (2007b) Feverish illness in children. Assessment and initial management in children younger than 5 years (NICE guideline). National Institute for Health and Clinical Excellence. www.nice.org.uk [Free Full-text]
  32. NTIS (2002) Use of chlorpheniramine in pregnancy. Newcastle upon Tyne: National Teratology Information Service, Regional Drug and Therapeutics Centre.
  33. Ogilvie, M.M. (1998) Antiviral prophylaxis and treatment in chickenpox: a review prepared for the UK Advisory Group on chickenpox on behalf of the British Society for the Study of Infection. Journal of Infection 36(Suppl 1), 31-38. [Abstract]
  34. Papadopoulos, A.J. (2007) Chickenpox. emedicine. WebMD. www.emedicine.com
  35. RCOG (2007) Chickenpox in pregnancy. Royal College of Obstetricians & Gynaecologists. www.rcog.org.uk [Free Full-text]
  36. Reilly, J.F. and Weisse, M.E. (1990) Topically induced diphenhydramine toxicity. Journal of Emergency Medicine 8(1), 59-61. [Abstract]
  37. Schaefer, C., Peters, P. and Miller, R.K. (Eds.) (2007) Drugs during pregnancy and lactation: treatment options and risk assessment. 2nd edn. Oxford: Academic Press.
  38. Stone, K.M., Reiff-Eldridge, R., White, A.D. et al. (2004) Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Research Part A: Clinical and Molecular Teratology 70(4), 201-207. [Abstract]
  39. Swingler, G. (2007) Chickenpox. Clinical Evidence. BMJ Publishing Group Ltd. www.clinicalevidence.com
  40. Tebruegge, M., Kuruvilla, M. and Margarson, I. (2006) Does the use of calamine or antihistamine provide symptomatic relief from pruritus in children with varicella zoster infection? Archives of Disease in Childhood 91(12), 1035-1036. [Free Full-text]
  41. Wallace, M.R., Bowler, W.A., Murray, N.B. et al. (1992) Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Annals of Internal Medicine 117(5), 358-363. [Abstract]
  42. WHO (2007) Mode of travel: health considerations. International Travel and Health 2007. World Health Organization. www.who.int [Free Full-text]
  43. Wilkins, E.G., Leen, C.L., McKendrick, M.W. and Carrington, D. (1998) Management of chickenpox in the adult: a review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. Journal of Infection 36(Suppl 1), 49-58.
  44. Woodward, G.A. and Baldassano, R.N. (1988) Topical diphenhydramine toxicity in a five year old with varicella. Pediatric Emergency Care 4(1), 18-20. [Abstract]
  45. Zerr, D.M., Alexander, E.R., Duchin, J.S. et al. (1999) A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 103(4 Pt 1), 783-790. [Abstract]

© NHS Institute for Innovation and Improvement